FENC
Fennec Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.62
−1.48%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- $0.09
- Revenue estimate
- $18.9M
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- $0.05
- EPS estimate
- $0.02
- Revenue actual
- $17.9M
- Revenue estimate
- $16.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 9
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -22.9%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $17
- PT range
- $16 – $18
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | $0.02 | $0.05 | Beat 150.00% | $17.9M |
| May 14, 2026 | -$0.02 | $0.01 | Beat 150.00% | $15.1M |
| Mar 24, 2026 | $0.03 | -$0.11 | Miss -466.67% | $13.8M |
| Nov 13, 2025 | -$0.08 | -$0.02 | Beat 75.00% | $12.5M |
| Aug 14, 2025 | -$0.06 | -$0.11 | Miss -83.33% | $9.7M |
| Mar 10, 2025 | $0.56 | -$0.06 | Miss -110.71% | $7.9M |
| Nov 7, 2024 | -$0.13 | -$0.21 | Miss -61.54% | $7.0M |
| Aug 13, 2024 | $0.06 | -$0.20 | Miss -433.33% | $7.3M |
| Mar 21, 2024 | -$0.02 | -$0.10 | Miss -400.00% | $9.7M |
| Aug 3, 2023 | -$0.18 | -$0.21 | Miss -16.67% | $3.3M |
| May 11, 2023 | -$0.21 | -$0.23 | Miss -9.52% | $1.7M |
| Nov 11, 2022 | -$0.17 | -$0.31 | Miss -82.35% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026